Posts

Intellectual Property Challenges in the Bio-Pharmaceutical Field

A Myriad of Problems: Genetic Patents Refused by High Court of Australia

The New USPTO Interim Guidance on Patent Subject Matter Eligibility

Myriad: does it make a difference in the real world?

News Flasche: Myriad ruling now out

Patentability of Isolated DNA: A Myriad of Analogies

Does patenting alienate customers? 23andme gets first US patent.

Letter from AmeriKat: 8,000,000, 3, 1970s, 1, $3,340, #24 - US IP News in Numbers